Amid the trade war with the US, Beijing’s regime is prioritizing technology as a key driver of economic and political power ...

Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...